Yttrium Y 90 Ibritumomab Tiuxetan
What is it? An anticancer drug that is a combination of a monoclonal antibody and a radioisotope (yttrium-90). Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells. Also called IDEC-Y2B8 monoclonal antibody.Added By: Nicole
The Yttrium Y 90 Ibritumomab Tiuxetan definition has been viewed 87 Time(s)!
Send To Friends!
If you'd like to send the Yttrium Y 90 Ibritumomab Tiuxetan definition to yourself or to your friends/colleagues, just enter the e-mail addresses in the boxes below -We hope you now understand the meaning of Yttrium Y 90 Ibritumomab Tiuxetan. If you need any more information on this term, please don't hesitate to contact us.